Maintenance of abstinence
Showing 1 - 25 of 6,731
Smoking Trial (AB-free kava, Placebo)
Not yet recruiting
- Smoking
- AB-free kava
- Placebo
- (no location specified)
Apr 3, 2023
Alcohol Use Disorder (AUD), Alcohol Dependence Trial (Sodium Oxybate, Placebo)
Completed
- Alcohol Use Disorder (AUD)
- Alcohol Dependence
- Sodium Oxybate
- Placebo
- (no location specified)
Dec 2, 2020
Alcohol Use Disorder With Insomnia Trial in Coatesville, Philadelphia (Topiramate (TOP), Cognitive Behavioral Therapy for
Recruiting
- Alcohol Use Disorder With Insomnia
- Topiramate (TOP)
- +2 more
-
Coatesville, Pennsylvania
- +1 more
Aug 5, 2021
Drug Addiction, Employment Trial (Employment-based abstinence reinforcement)
Not yet recruiting
- Drug Addiction
- Employment
- Employment-based abstinence reinforcement
- (no location specified)
Sep 6, 2022
Cannabis Use Disorder Trial in Parkville (Guanfacine Extended Release Oral Tablet, Residential withdrawal, Engagement with
Not yet recruiting
- Cannabis Use Disorder
- Guanfacine Extended Release Oral Tablet
- +3 more
-
Parkville, Victoria, AustraliaOrygen
Jul 16, 2023
Maternal Opioid Use Disorder, Opioid Exposed Infant Trial in Baltimore (fetal monitoring, Buprenorphine Naloxone, Methadone)
Recruiting
- Maternal Opioid Use Disorder
- Opioid Exposed Infant
- fetal monitoring
- +2 more
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center
Dec 30, 2022
Severe Alcohol Use Disorder (DSM 5) Trial in Paris (Placebo, Half dose, Full dose)
Not yet recruiting
- Severe Alcohol Use Disorder (DSM 5)
- Placebo
- +2 more
-
Paris, FranceHôpital Fernand Widal
May 5, 2023
Smoking Cessation, Hiv Trial (Screening, Brief Intervention and Referral to Treatment (SBIRT) intervention consisting of the
Not yet recruiting
- Smoking Cessation
- Hiv
- Screening, Brief Intervention and Referral to Treatment (SBIRT) intervention consisting of the 5As, (Ask, Advise, Assess, Assist, Arrange)
- Varenicline
- (no location specified)
Jan 11, 2023
Alcohol Abuse, Arteriosclerosis Trial in Shenzhen (Ligustrazine by intravenously administration, Ligustrazine by mouth, Placebo
Not yet recruiting
- Alcohol Abuse
- Arteriosclerosis
- Ligustrazine by intravenously administration
- +3 more
-
Shenzhen, Guangdong, ChinaShenzhen Kangning Hospital
Jul 4, 2023
Smoking Trial in San Francisco (behavioral relapse prevention counseling, hypnosis for relapse prevention)
Completed
- Smoking
- behavioral relapse prevention counseling
- hypnosis for relapse prevention
-
San Francisco, CaliforniaVeterans Affairs Medical Center, 4150 Clement Street
Mar 7, 2022
Opioid-use Disorder, Cocaine Use Disorder, Opioid Use Trial in Oconomowoc, Wauwatosa (App-Based Contingency Management, Sham
Recruiting
- Opioid-use Disorder
- +6 more
- App-Based Contingency Management
- Sham Control
-
Oconomowoc, Wisconsin
- +1 more
Dec 1, 2022
Smoking Cessation Trial in Dijon (Transcranial Magnetic Stimulation sessions, Evaluations)
Recruiting
- Smoking Cessation
- Transcranial Magnetic Stimulation sessions
- Evaluations
-
Dijon, FranceChu Dijon Bourgogne
Jan 11, 2022
Cocaine Use Disorder Trial in Pittsburgh (Prize-Based Contingency Management, Treatment As Usual Outpatient Substance Use
Recruiting
- Cocaine Use Disorder
- Prize-Based Contingency Management
- Treatment As Usual Outpatient Substance Use Treatment
-
Pittsburgh, PennsylvaniaVA Pittsburgh Healthcare System University Drive Division, Pitts
Nov 14, 2022
Smoking, Smoking Behaviors, Nicotine Dependence Trial in New Haven (Vuse Alto E-cigarette with 3% Nicotine with Menthol and
Not yet recruiting
- Smoking
- +2 more
- Vuse Alto E-cigarette with 3% Nicotine with Menthol and Tobacco Flavors
- +7 more
-
New Haven, ConnecticutYale University
Oct 4, 2023
Substance Abuse, Cocaine Dependence Trial in Baltimore (Placebo, Bupropion XL, Abstinence Initiation)
Completed
- Substance Abuse
- Cocaine Dependence
- Placebo
- +3 more
-
Baltimore, Maryland
- +1 more
Aug 24, 2021
Tobacco Use Disorder, Diabetes, Type 2 Trial in Sevilla (Control group (waiting list), Cognitive Behavioral Treatment (CBT) for
Not yet recruiting
- Tobacco Use Disorder
- Diabetes Mellitus, Type 2
- Control group (waiting list)
- +2 more
-
Sevilla, SpainCarla López Núñez
May 22, 2023
Tobacco Smoking Trial in Omaha (Genetic Education Session, Nutrition Education Session)
Completed
- Tobacco Smoking
- Genetic Education Session
- Nutrition Education Session
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Dec 6, 2022
Alcohol Use Disorder Trial in Brussels (Neurofeedback active, Neurofeedback )
Recruiting
- Alcohol Use Disorder
- Neurofeedback active
- Neurofeedback placebo
-
Brussels, BelgiumCHU Brugmann
Jun 12, 2023
Insomnia, Alcohol Use Disorder Trial in Melbourne (Suvorexant 20 mg, )
Recruiting
- Insomnia
- Alcohol Use Disorder
- Suvorexant 20 mg
- placebo
-
Melbourne, Victoria, AustraliaSt Vincent's Hospital
Aug 16, 2021
Nicotine Dependence Trial in Baltimore (Transcranial Direct Current Stimulation, Sham)
Suspended
- Nicotine Dependence
- Transcranial Direct Current Stimulation
- sham
-
Baltimore, MarylandNational Institute on Drug Abuse
Jan 4, 2023
Hiv, Opioid Dependence, Smoking Cessation Trial in Kilimani (drug, behavioral, other)
Recruiting
- Hiv
- +2 more
- Bupropion
- +2 more
-
Kilimani, Nairobi, KenyaCenter for International Health, Education, and Biosecurity (CIH
Jan 4, 2022
Opioid Use, Chronic Pain Trial in New Brunswick (Mindfulness Oriented Recovery Enhancement, Methadone Treatment as Usual)
Completed
- Opioid Use
- Chronic Pain
- Mindfulness Oriented Recovery Enhancement
- Methadone Treatment as Usual
-
New Brunswick, New JerseyRutgers Robert Wood Johnson Medical School
Jun 16, 2022
Smoking Cessation, Substance-Related Disorders Trial in Bronx (Varenicline, Placebo)
Completed
- Smoking Cessation
- Substance-Related Disorders
- Varenicline
- Placebo
-
Bronx, New YorkAlbert Einstein College of Medicine of Yeshiva University
May 4, 2021